YOLFTbeta
GlucoTrack Inc

GlucoTrack Inc

GCTK · NASDAQ · Healthcare / Medical Devices

0.2168USD-0.02 (-9.67%)

Price History

Full chart

Market Stats

Previous Close0.24
Open0.24
Day Range0.2168 – 0.24
52-Week Range1.77 – 136.29
Volume7.38K
Market Cap2.06M
P/E (TTM)0.15
Forward P/E0.00
EPS17.25
Dividend Yield0.00%
Beta0.62
50-Day Avg4.74
200-Day Avg20.30

About

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Erik C. Emerson
  • Employees15
  • Headquarters301 Route 17 North, Rutherford, NJ, United States, 07070, USA
  • Websitehttps://glucotrack.com

Leadership

  • Mr. Erik C. EmersonCEO & Director · b. 1971
  • Mr. David Malka BACo-Founder · b. 1965
  • Mr. Vincent WongChief Operations Officer
  • Dr. Mark Tapsak Ph.D.Chief Scientific Officer · b. 1969
  • Ms. Drinda BenjaminChief Commercial Officer · b. 1976

Financials

Income Statement

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----59.77K143.17K611.69K589.46K43.49K208.00K70.78K00000
Growth (%)------+139.51%+327.26%-3.63%-92.62%+378.29%-65.97%-100.00%----
Cost of Revenue---47.5462.48K65.97K44.89K59.58K140.21K95.56K51.00K47.00K42.00K23.00K13.00K36.00K-
Gross Profit----47.54-62.48K59.77K98.28K552.11K449.25K-52.08K208.00K-47.00K-42.00K-23.00K-13.00K-36.00K-
Gross Margin-----100.00%68.64%90.26%76.21%-119.75%100.00%-66.40%-----
Operating Expense----2.77M-3.09M-3.55M-4.56M-5.10M-10.13M-6.59M-3.30M3.08M4.00M4.41M7.09M14.51M-
Operating Income1.17M1.39M-2.33M2.77M3.03M3.61M4.66M5.66M10.58M6.54M3.51M-3.13M-4.04M-4.43M-7.10M-14.55M-16.09M
Operating Margin-----6034.90%3251.69%924.63%1794.15%15035.41%1685.58%-4425.10%-----
EBITDA-1.17M-2.50M-2.31M-2.73M-2.99M-3.57M-5.78M-5.33M-10.24M-6.64M-3.46M-3.08M-3.94M-4.41M-7.08M-21.93M-19.35M
EBITDA Margin------5976.87%-4038.69%-872.00%-1736.59%-15264.76%-1661.06%-4358.70%-----
Net Income-1.20M-2.79M-2.36M-2.77M-9.80M2.98M-5.84M-5.41M-10.33M-6.72M-3.52M-2.70M-4.07M-4.43M-7.10M-22.60M-19.39M
Net Income Margin-----4986.07%-4080.67%-884.39%-1752.24%-15442.01%-1690.38%-3809.09%-----
R&D1.01M934.06K1.79M1.92M1.99M1.85M2.27M2.88M3.21M3.03M1.61M1.53M1.81M1.97M4.70M9.50M9.81M
R&D as % of Total Revenue-----3094.31%1584.40%471.12%544.13%6974.02%772.12%2164.51%-----
Interest Expense32.03K1.40M30.89K6.61K17.59K6.59M15.21K16.22K24.40K18.29K10.00K98.00K4.16M3.00K0628.00K-
Interest Expense % of Total Revenue-----11020.97%10.62%2.65%4.14%42.06%4.81%138.46%-----

Balance Sheet

Currency: USD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--2.18M814.57K2.76M6.35M2.13M2.46M1.67M688.19K1.10M10.61M6.26M2.44M4.91M5.93M7.84M
Total Liabilities--1.21M1.32M13.82M11.18M9.10M13.41M18.24M3.56M2.51M1.62M1.11M1.21M1.71M18.93M5.01M
Total Equity--968.24K-503.07K-11.06M-4.83M-6.97M-10.95M-16.57M-2.87M-1.41M8.98M5.16M1.23M3.20M-13.00M2.83M
Cash--1.90M543.41K2.39M5.83M608.70K148.84K53.78K97.08K419.00K9.82M6.06M2.31M4.49M5.62M7.38M
Total Debt--606.14K37.43K693.09K617.99K160.31K162.03K182.77K168.22K378.00K363.00K250.00K195.00K196.00K267.00K33.00K
Net Debt---1.29M-505.98K-1.69M-5.21M-448.39K13.20K128.99K71.14K-41.00K-9.46M-5.81M-2.12M-4.30M-5.35M-7.35M

Cash Flow

Currency: USD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.37M-1.92M-2.30M-3.22M-3.36M-4.57M-5.31M-5.90M-4.89M-3.90M-3.50M-3.77M-3.73M-6.56M-12.49M-15.24M
Investing Cash Flow-29.32K-40.18K-17.73K-104.28K-91.51K-203.17K-76.45K-19.47K-5.37K-23.43K-53.00K-1.00K1.00K--104.00K-96.00K
Financing Cash Flow2.90M2.38M953.53K5.06M6.97M-460.86K4.94M5.75M4.96M4.20M13.01M008.73M13.74M17.04M
Capital Expenditure8.72K54.62K11.35K64.25K63.45K143.74K76.45K19.47K5.37K23.43K53.00K5.00K1.00K0104.00K96.00K
Free Cash Flow-1.38M-1.97M-2.31M-3.28M-3.43M-4.71M-5.39M-5.91M-4.90M-3.92M-3.55M-3.77M-3.73M-6.56M-12.59M-15.34M
Dividends Paid---288.25K370.44K57.06K13.53K5.73K0-------
FCF to OCF100.64%102.85%100.49%102.00%101.89%103.15%101.44%100.33%100.11%100.60%101.51%100.13%100.03%100.00%100.83%100.63%
Dividend Paid to FCF----8.78%-10.82%-1.21%-0.25%-0.10%0.00%-------

Earnings

Report DateJun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016May 15, 2017Aug 14, 2017Nov 14, 2017Mar 30, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Dec 31, 2018Apr 15, 2019Aug 14, 2019Nov 13, 2019Dec 31, 2019Apr 14, 2020Aug 14, 2020Nov 12, 2020Dec 31, 2020Apr 13, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 31, 2025May 14, 2025Aug 14, 2025Nov 13, 2025Aug 14, 2026Nov 12, 2026
EPS Estimate------------------------------------------------0.00--
EPS Actual-9771.41-11637.10-106978.51-12202.2460900.62-12765.52-11735.01-24004.32-25743.91-16776.44-23400.00-18564.56-23707.61-23016.90-18307.47-0.48-0.48-0.44-0.47-0.34-0.33-0.31-17848.62-3.13-0.01-0.01-286.86-0.05-0.04-0.03-341.49-0.01-0.72-0.05-0.10-0.07-0.07-0.06-0.08-327.25-580.70-692.70-703.61-983.76-1091.07-19.51-40.35-9.62-4.64-0.76-
Surprise---------------------------------------------------
Timing---------------------------------------------------

Key Statistics & Ratios

Market Cap2.06M
Enterprise Value2.46M
Trailing P/E0.15
Forward P/E0.00
Price / Sales526.95
Price / Book0.65
EPS17.25
Book Value-4.17
Revenue (TTM)0
Gross Profit (TTM)-20.00K
EBITDA-15.33M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-620.63%
Return on Assets-164.45%
Shares Outstanding798.39K
Shares Float636.24K
Beta0.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
12.19%
Insiders
7.98%
Retail / Other
79.83%

Top Institutional Holders

  • Geode Capital Management, LLC
    47.00K0.44%
  • Ikarian Capital, LLC
    45.83K0.43%
  • HRT FINANCIAL LLC
    40.63K0.38%
  • GRANITE ISLANDS PRIVATE WEALTH, LLC
    15.70K0.15%
  • BOOTHBAY FUND MANAGEMENT, LLC
    13.53K0.13%
  • Vanguard Fiduciary Trust Co
    4.72K0.04%
  • ALERUS FINANCIAL NA
    4.00K0.04%
  • Tower Research Capital LLC
    3.44K0.03%
  • PlanVest Financial, Inc
    1.00K0.01%
  • UBS Group AG
    7020.01%
  • Tradewinds Capital Management, LLC
    500.00%
  • Newbridge Financial Services Group, Inc.
    340.00%
  • SBI Securities Co Ltd
    90.00%
  • Morgan Stanley - Brokerage Accounts
    20.00%
  • Advisor Group Holdings, Inc.
    20.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    33.26K0.28%
  • Fidelity Series Total Market Index
    4500.00%

Stock Splits

  • Oct 26, 20261:2
  • Aug 31, 20261:15
  • Jun 16, 20251:60
  • Feb 4, 20251:20
  • May 20, 20241:5
  • Aug 13, 20211:13